Pregled bibliografske jedinice broj: 1189200
COVID-19 vaccinations: summary guidance for cancer patients in 28 languages: breaking barriers to cancer patient information
COVID-19 vaccinations: summary guidance for cancer patients in 28 languages: breaking barriers to cancer patient information // Reviews on Recent Clinical Trials, 17 (2022), 1; 11-14 doi:10.2174/1574887116666211028145848 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1189200 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
COVID-19 vaccinations: summary guidance for cancer patients in 28 languages: breaking barriers to cancer patient information
Autori
Mauri, Davide ; Kamposioras, Konstantinos ; Tsali, Lampriani ; Dambrosio, Mario ; De Bari, Berardino ; Hindi, Nadia ; Salembier, Carl ; Nixon, Joanna ; Dimitrios, Tzachanis ; Alongi, Flippo ; Hameed, Hassan ; Valachis, Antonios ; Papadimitriou, Konstantinos ; Corradini, Stefanie ; Popovic, Lazar ; Kopecky, Jindrich ; Rodriguez, Andres ; Antunac, Katarina ; Yi, Junlin ; Lovey, Jozsef ; Strojan, Primoz ; Saraireh, Haytham ; Røtterud, Ranveig ; Chojnacka, Marzanna ; Olalla, Santa Cruz ; Chilingirova, Natalia ; De Mello, Ramon Andrade ; Araujo Amaral, Giovanna ; Arbabi, Farsid ; Vidra, Radu ; Rapushi, Erjeta ; Takeuchi, Dan ; Christopoulos, Chirstos ; Ivanova, Irina ; Djan, Igor ; Petričević, Branka ; Cellini, Francesco ; Mihaylova, Iglika ; Dedić Plavetić, Natalija ; Grašič Kuhar, Cvetka ; Takeuchi, Elena ; Kountourakis, Pantelis ; Ntellas, Panagiotis ; Gazouli, Ioanna ; Gkoura, Stefania ; Yuce, Salih ; ER, Özlem ; Yasmina, Chait ; Kumaran, Gireesh ; Spahiu, Orges ; Yusuf, Aasim ; Gono, Paulina ; Apostolidis, Kathi ; Tolia, Maria
Izvornik
Reviews on Recent Clinical Trials (1574-8871) 17
(2022), 1;
11-14
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
COVID-19 ; cancer ; pandemic ; vaccination
Sažetak
Background Covid-19 vaccination has started in the majority of the countries at the global level. Cancer patients are at high risk for infection, serious illness, and death from COVID-19 and need vaccination guidance and support. Guidance availability in the English language only is a major limit for recommendations’ delivery and their application in the world’s population and generates information inequalities across the different populations. Methods Most of the available COVID-19 vaccination guidance for cancer patients was screened and scrutinized by the European Cancer Patients Coalition (ECPC) and an international oncology panel of 52 physicians from 33 countries.Results: A summary guidance was developed and provided in 28 languages in order to reach more than 70 percent of the global population. Conclusion Language barrier and e-guidance availability in the native language are the most important barriers when communicating with patients. E-guidance availability in various native languages should be considered a major priority by international medical and health organizations that are communicating with patients at the global level.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus
- MEDLINE